Standout Papers
Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Genetic determinants of hepatic steatosis in man
2011
Genetic Polymorphisms and the Progression of Liver Fibrosis: A Critical Appraisal
2003
The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes
2009
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
2004
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver
2004
Thiazolidinediones
2004 Standout
HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity
2002
Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States
2003
Non‐alcoholic steatohepatitis: Definitions and pathogenesis
2002
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease
2004
Interrelationships of alcohol and iron in liver disease with particular reference to the iron‐binding proteins, ferritin and transferrin
1999
Liver fibrosis
2005 Standout
Genetic modifiers of non-alcoholic fatty liver disease progression
2011
Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver
2000
Global Cancer Statistics, 2002
2005 Standout
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
2014 Standout
Nonalcoholic fatty liver disease
2002
Steatosis: Co-factor in Other Liver Diseases *
2005
Haemochromatosis in the new millenium
2000
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
2004
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
1999
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Head and neck cancer
2008 Standout
Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice
2004
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Steatohepatitis in children
2002
Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis
2003
Current topics in the epidemiology of oral cavity and oropharyngeal cancers
2007
Alcohol and public health
2005 Standout
Update on Nonalcoholic Fatty Liver Disease
2002
Effects of iron overload on chronic metabolic diseases
2014
Phytochromes and light signal perception by plants—an emerging synthesis
2000 StandoutNature
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Non‐alcoholic fatty liver disease: An overview
2002
AGA technical review on nonalcoholic fatty liver disease
2002
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses
2007 Standout
Liver Damage in Obese Patients
2002
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Liver fibrosis in overweight patients
2000
Genetic susceptibility–molecular epidemiology of head and neck cancer
2002
Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis
1999
Cleft lip and palate
2009 Standout
The metabolic syndrome
2005 Standout
Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease
2001
Non-alcoholic fatty liver disease
2021 Standout
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
2001
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
2010
Factors Associated or Related to with Pathological Severity of Nonalcoholic Fatty Liver Disease
2004
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma
2002
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
2013
A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
2001 Standout
Nonalcoholic Steatohepatitis in Children
2000
Hepatic steatosis: Innocent bystander or guilty party?
1998
Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease
2005
Epidemiology, Staging, and Screening of Head and Neck Cancer
2006
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Mutations of the HFE gene in patients with hepatocellular carcinoma
2003
Type 1 diabetes
2013 Standout
Hepatic iron and nonalcoholic fatty liver disease
1999
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity
2000
Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck
2007
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
1999 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease
2002
HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
2009
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
1999 Standout
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda
2001 Standout
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
2002
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
1999
Association of nonalcoholic fatty liver disease with insulin resistance
1999
Nonalcoholic fatty liver disease
2005 Standout
Alcohol dehydrogenase 3 genotype modification of the associationof alcohol consumption with breast cancer risk
1999
Disorders of Iron Metabolism
1999 Standout
Perspectives of identity by descent (IBD) mapping in founder populations
1995
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Health-system strengthening and tuberculosis control
2010
NF-κB Activation, Rather Than TNF, Mediates Hepatic Inflammation in a Murine Dietary Model of Steatohepatitis
2005
Hepatocellular Carcinoma
2011 Standout
Interaction between the ADH1C polymorphism and maternal alcohol intake in the risk of nonsyndromic oral clefts: An evaluation of the contribution of child and maternal genotypes
2004
Randomized Placebo-Controlled Trial of Ursodeoxycholic Acid With Vitamin E in Nonalcoholic Steatohepatitis
2006
Insulin resistance–associated hepatic iron overload
1999
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
2011
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
2003
Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: A study in monozygotic and dizygotic twins
2009
The potential role of genes in nonalcoholic fatty liver disease
2004
Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma
2002
Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1
2024 StandoutNobel
Approach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis
2004
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
2022
Treatment of nonalcoholic fatty liver disease
2002
Nonalcoholic Fatty Liver Disease
2001 Standout
Mutations of the HFE gene in patients with hepatocellular carcinoma
2003
The ins and outs of mitochondrial dysfunction in NASH
2004
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Genes affecting phenotypic plasticity in Arabidopsis: pleiotropic effects and reproductive fitness of photomorphogenic mutants
1999
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Nonalcoholic Steatohepatitis in Children
2000
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Free radicals and apoptosis: relationships with glutathione, thioredoxin and the BCL family of proteins
2005
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Iron-Deficiency Anemia
2015 Standout
A high‐fat diet leads to the progression of non‐alcoholic fatty liver disease in obese rats
2004
Per- and polyfluoroalkyl substances in the environment
2022 StandoutScience
Nonalcoholic Fatty Liver Disease
2015 Standout
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Strategies for improving the acceptability and acceptance of the copper intrauterine device
2012
HFE Genotype in Patients with Hemochromatosis and Other Liver Diseases
1999
Works of Patrick J. Ward being referenced
Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms
1997
Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3
2001
Positive associations of serum perfluoroalkyl substances with uric acid and hyperuricemia in children from Taiwan
2016
Increasing body weight predicts the earlier onset of insulin‐dependant diabetes in childhood: testing the ‘accelerator hypothesis’ (2)
2004
Increasing contraceptive use in rural Pakistan: an evaluation of the Lady Health Worker Programme
2005
Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis
1998
Some developments on the affected-pedigree-member method of linkage analysis.
1993
Role of alcohol dehydrogenase 3 and cytochrome P‐4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract
2000
3-Phosphoinositide-Dependent Protein Kinase-1/Akt Signaling Represents a Major Cyclooxygenase-2-Independent Target for Celecoxib in Prostate Cancer Cells
2004
Parent-offspring regression and extreme environments
1994
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial
2019
Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract
2000